Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 73651 - 73675 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Silicon dioxide	Approved	WFDC5	149708	downregulated	Silicon Dioxide analog results in decreased expression of WFDC5 mRNA	20q13.12	A24195
Silicon dioxide	Approved	WHRN	25861	upregulated	Silicon Dioxide analog results in increased expression of WHRN mRNA	9q32	A24195
Silicon dioxide	Approved	WIPF1	7456	downregulated	Silicon Dioxide analog results in decreased expression of WIPF1 mRNA	2q31.1	A24195
Silicon dioxide	Approved	WLS	79971	upregulated	Silicon Dioxide analog results in increased expression of WLS mRNA	1p31.3	A24195
Silicon dioxide	Approved	WNK4	65266	downregulated	Silicon Dioxide analog results in decreased expression of WNK4 mRNA	17q21.2	A24195
Silicon dioxide	Approved	WNT10B	7480	upregulated	Silicon Dioxide analog results in increased expression of WNT10B mRNA	12q13.12	A24195
Silicon dioxide	Approved	WNT11	7481	upregulated	Silicon Dioxide analog results in increased expression of WNT11 mRNA	11q13.5	A24195
Silicon dioxide	Approved	WNT2	7472	upregulated	Silicon Dioxide results in increased expression of WNT2 mRNA	7q31.2	A24200
Silicon dioxide	Approved	WNT3A	89780	downregulated	Silicon Dioxide analog results in decreased expression of WNT3A mRNA	1q42.13	A24195
Silicon dioxide	Approved	WNT3A	89780	downregulated	Silicon Dioxide results in decreased expression of WNT3A mRNA	1q42.13	A24198
Silicon dioxide	Approved	WNT5A	7474	downregulated	Silicon Dioxide analog results in decreased expression of WNT5A mRNA	3p14.3	A24194
Silicon dioxide	Approved	WNT5A	7474	downregulated	Silicon Dioxide results in decreased expression of WNT5A mRNA	3p14.3	A24196 A24198
Silicon dioxide	Approved	WNT5B	81029	downregulated	Silicon Dioxide analog results in decreased expression of WNT5B mRNA	12p13.33	A24195
Silicon dioxide	Approved	WNT6	7475	downregulated	Silicon Dioxide analog results in decreased expression of WNT6 mRNA	2q35	A24195
Silicon dioxide	Approved	WNT7A	7476	upregulated	Silicon Dioxide analog results in increased expression of WNT7A mRNA	3p25.1	A24195
Silicon dioxide	Approved	WSB1	26118	downregulated	Silicon Dioxide results in decreased expression of WSB1 mRNA	17q11.1	A24196
Silicon dioxide	Approved	WWC1	23286	upregulated	Silicon Dioxide analog results in increased expression of WWC1 mRNA	5q34	A24194
Silicon dioxide	Approved	WWOX	51741	upregulated	Silicon Dioxide analog results in increased expression of WWOX mRNA	16q23.1-q23.2	A24195
Silicon dioxide	Approved	WWOX	51741	downregulated	Silicon Dioxide results in decreased expression of WWOX mRNA	16q23.1-q23.2	A24196
Silicon dioxide	Approved	WWTR1	25937	upregulated	Silicon Dioxide results in increased expression of WWTR1 mRNA	3q25.1	A24196
Silicon dioxide	Approved	XBP1	7494	downregulated	Silicon Dioxide analog results in decreased expression of XBP1 mRNA	22q12.1	A24195
Silicon dioxide	Approved	XCL1	6375	upregulated	Silicon Dioxide analog results in increased expression of XCL1 mRNA	1q24.2	A24194
Silicon dioxide	Approved	XCR1	2829	downregulated	Silicon Dioxide results in decreased expression of XCR1 mRNA	3p21.31	A24203
Silicon dioxide	Approved	XDH	7498	upregulated	Silicon Dioxide results in increased expression of XDH mRNA	2p23.1	A24196
Silicon dioxide	Approved	XIAP	331	downregulated	Silicon Dioxide results in decreased expression of XIAP mRNA	Xq25	A24196

Displaying entries 73651 - 73675 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability